Targinact: targets opioid‐induced constipation

Targinact, licensed for severe pain, is a formulation of prolonged‐release oxycodone with the addition of naloxone to improve opioid‐induced bowel dysfunction. Here, the authors discuss the clinical data relating to its efficacy and adverse effects, and describe its place in treatment. Copyright © 2009 Wiley Interface Ltd.